BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 762813)

  • 1. Step 2 regimens in hypertension. An assessment.
    Finnerty FA; Gyftopoulos A; Berry C; McKenney A
    JAMA; 1979 Feb; 241(6):579-81. PubMed ID: 762813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in the elderly: review of therapy with a hydroflumethiazide-reserpine combination.
    Elkowitz EB
    J Am Geriatr Soc; 1979 Nov; 27(11):507-10. PubMed ID: 489858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria.
    Olatunde A; Akinkugbe OO; Carlisle R
    East Afr Med J; 1977 Apr; 54(4):194-201. PubMed ID: 902626
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of effect of single daily doses of reserpine and hydroflumethiazide evaluated by noninvasive technology in hypertensive patients.
    Gifford RW; Williams GW; Vidt DG; Bolen K; Acker C
    Cleve Clin Q; 1982; 49(4):209-18. PubMed ID: 7168911
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
    Stein CM; Neill P; Mwaluko GM; Kusema T
    S Afr Med J; 1990 Mar; 77(5):243-5. PubMed ID: 2107581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the use of reserpine versus alpha-methyldopa for second step treatment of hypertension in the elderly.
    Applegate WB; Carper ER; Kahn SE; Westbrook L; Linton M; Baker MG; Runyan JW
    J Am Geriatr Soc; 1985 Feb; 33(2):109-15. PubMed ID: 3968365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in the treatment of essential hypertension.
    JAMA; 1977 May; 237(21):2303-10. PubMed ID: 323525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension with a new kind of drug combination].
    Emich R; Roiko G
    Wien Med Wochenschr; 1968 Oct; 118(40):822-5. PubMed ID: 5710853
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug choice for treatment of hypertension at 'step 2'.
    Feigenbaum LZ
    West J Med; 1979 Apr; 130(4):391-3. PubMed ID: 442637
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass.
    Weinstein M; Hilewitz H; Rogel S
    Arch Intern Med; 1984 Aug; 144(8):1629-32. PubMed ID: 6235790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrochlorothiazide plus methyldopa in the treatment of isolated systolic hypertension in the elderly.
    Boyles PW
    Clin Ther; 1984; 6(6):793-9. PubMed ID: 6509462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug combinations as rational antihypertensive therapy.
    Gifford RW
    Arch Intern Med; 1974 Jun; 133(6):1053-7. PubMed ID: 4151443
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
    Fernandez PG; Zachariah PK; Bryant DG; Missan SS
    Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.